Newsroom
  • January 5 , 2024

    MediLink Therapeutics and Roche Reach Exclusive Global License Agreement to Collaborate on the Development of Next-generation ADC for Cancer Treatment

    Read more
  • January 2 , 2024

    U.S. FDA Approves Label Update For Kite’s Yescarta® CAR T-Cell Therapy To Include Overall Survival Data

    Read more
  • December 27 , 2023

    Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases

    Read more
  • December 25 , 2023

    Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics

    Read more
  • December 21 , 2023

    GSK enters exclusive license agreement with Hansoh for HS-20093

    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us